Suppr超能文献

中东呼吸综合征冠状病毒的发病机制

Pathogenesis of Middle East respiratory syndrome coronavirus.

作者信息

van den Brand Judith M A, Smits Saskia L, Haagmans Bart L

机构信息

Department of Viroscience, Erasmus Medical Centre, Rotterdam, The Netherlands.

出版信息

J Pathol. 2015 Jan;235(2):175-84. doi: 10.1002/path.4458.

Abstract

Human coronaviruses (CoVs) mostly cause a common cold that is mild and self-limiting. Zoonotic transmission of CoVs such as the recently identified Middle East respiratory syndrome (MERS)-CoV and severe acute respiratory syndrome (SARS)-CoV, on the other hand, may be associated with severe lower respiratory tract infection. This article reviews the clinical and pathological data available on MERS and compares it to SARS. Most importantly, chest radiographs and imaging results of patients with MERS show features that resemble the findings of organizing pneumonia, different from the lesions in SARS patients, which show fibrocellular intra-alveolar organization with a bronchiolitis obliterans organizing pneumonia-like pattern. These findings are in line with differences in the induction of cytopathological changes, induction of host gene responses and sensitivity to the antiviral effect of interferons in vitro when comparing both MERS-CoV and SARS-CoV. The challenge will be to translate these findings into an integrated picture of MERS pathogenesis in humans and to develop intervention strategies that will eventually allow the effective control of this newly emerging infectious disease.

摘要

人类冠状病毒(CoVs)大多引起普通感冒,症状轻微且具有自限性。另一方面,冠状病毒的人畜共患传播,如最近发现的中东呼吸综合征(MERS)冠状病毒和严重急性呼吸综合征(SARS)冠状病毒,可能与严重的下呼吸道感染有关。本文综述了有关MERS的临床和病理数据,并将其与SARS进行比较。最重要的是,MERS患者的胸部X光片和影像学结果显示出类似于机化性肺炎的特征,这与SARS患者的病变不同,SARS患者的病变表现为纤维细胞性肺泡内组织,呈闭塞性细支气管炎机化性肺炎样模式。当比较MERS-CoV和SARS-CoV时,这些发现与细胞病理学变化的诱导、宿主基因反应诱导以及体外对干扰素抗病毒作用的敏感性差异一致。挑战将是把这些发现转化为人类MERS发病机制的综合图景,并制定最终能够有效控制这种新出现传染病的干预策略。

相似文献

4
Broad-spectrum coronavirus antiviral drug discovery.广谱冠状病毒抗病毒药物的发现。
Expert Opin Drug Discov. 2019 Apr;14(4):397-412. doi: 10.1080/17460441.2019.1581171. Epub 2019 Mar 8.
8
Remdesivir against COVID-19 and Other Viral Diseases.瑞德西韦治疗 COVID-19 及其他病毒性疾病。
Clin Microbiol Rev. 2020 Oct 14;34(1). doi: 10.1128/CMR.00162-20. Print 2020 Dec 16.

引用本文的文献

9
Nature of viruses and pandemics: Coronaviruses.病毒与大流行的本质:冠状病毒
Curr Res Immunol. 2022;3:151-158. doi: 10.1016/j.crimmu.2022.08.003. Epub 2022 Aug 8.
10
SARS-CoV-2 pathogenesis.严重急性呼吸综合征冠状病毒 2 型的发病机制。
Nat Rev Microbiol. 2022 May;20(5):270-284. doi: 10.1038/s41579-022-00713-0. Epub 2022 Mar 30.

本文引用的文献

8
Infection control and MERS-CoV in health-care workers.医护人员中的感染控制与中东呼吸综合征冠状病毒
Lancet. 2014 May 31;383(9932):1869-71. doi: 10.1016/S0140-6736(14)60852-7. Epub 2014 May 20.
10
Middle East respiratory syndrome coronavirus disease in children.儿童中东呼吸综合征冠状病毒病
Pediatr Infect Dis J. 2014 Sep;33(9):904-6. doi: 10.1097/INF.0000000000000325.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验